ConductScience.org, home

Paper2017258

Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.

Rivière Y and 3 others. Nature, 1991. Cited by 168 papers, by iCite.

Cite this record

ConductScience Library. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Papers, record 2017258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2017258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
PubMed
Journal
Nature
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
168
iCite
Relative citation ratio, by iCite
3.16
iCite
Revised in PubMed
2026-10-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rivière YY
2Blank VV
3Kourilsky PP
4Israël AA

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV ProteaseMajor topic
HIV-1Major topic
NF-kappa BMajor topic
Protein PrecursorsMajor topic
Protein Processing, Post-TranslationalMajor topic
Cell Line
Cell Nucleus
Cell Transformation, Viral
Humans
Methionine
T-Lymphocytes

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12691328A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.Genes Dev1989https://conductscience.org/library/papers/2691328PubMed
23129195Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.Cell1988https://conductscience.org/library/papers/3129195PubMed
32665943NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.Cell1989https://conductscience.org/library/papers/2665943PubMed
42644644Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2644644PubMed
52503623Cell surface expression of several species of human immunodeficiency virus type 1 major core protein.J Virol1989https://conductscience.org/library/papers/2503623PubMed
62647305Retroviral proteases: first glimpses at the anatomy of a processing machine.Cell1989https://conductscience.org/library/papers/2647305PubMed
72203531The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.Cell1990https://conductscience.org/library/papers/2203531PubMed
83322806Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers.EMBO J1987https://conductscience.org/library/papers/3322806PubMed
93140380I kappa B: a specific inhibitor of the NF-kappa B transcription factor.Science1988https://conductscience.org/library/papers/3140380PubMed
103031512An inducible transcription factor activates expression of human immunodeficiency virus in T cells.Nature1987https://conductscience.org/library/papers/3031512PubMed
112203532Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.Cell1990https://conductscience.org/library/papers/2203532PubMed

Download CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 168 citations.

PMIDTitleJournalYearIn PapersSource
38439942Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies.Front Immunol2023https://conductscience.org/library/papers/38439942PubMed
36992421Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg?Viruses2023https://conductscience.org/library/papers/36992421PubMed
33471274FHA domain of AGGF1 is essential for its nucleocytoplasmic transport and angiogenesis.Sci China Life Sci2021https://conductscience.org/library/papers/33471274PubMed
32214470Organization and regulation of nucleocytoplasmic transport.Mol Biol2010https://conductscience.org/library/papers/32214470PubMed
31462935A human endogenous retrovirus encoded protease potentially cleaves numerous cellular proteins.Mob DNA2019https://conductscience.org/library/papers/31462935PubMed
30742233The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.Cell Mol Life Sci2019https://conductscience.org/library/papers/30742233PubMed
30597859Focus on Translation Initiation of the HIV-1 mRNAs.Int J Mol Sci2018https://conductscience.org/library/papers/30597859PubMed
26779410Translation initiation of the HIV-1 mRNA.Translation (Austin)2014https://conductscience.org/library/papers/26779410PubMed
25429850Components and regulation of nuclear transport processes.FEBS J2015https://conductscience.org/library/papers/25429850PubMed
25196285Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.Viruses2014https://conductscience.org/library/papers/25196285PubMed
24796579In silico prediction of mutant HIV-1 proteases cleaving a target sequence.PLoS One2014https://conductscience.org/library/papers/24796579PubMed
22069564Toxin-based therapeutic approaches.Toxins (Basel)2010https://conductscience.org/library/papers/22069564PubMed
20004167Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance.Structure2009https://conductscience.org/library/papers/20004167PubMed
16956392HIV-2 Protease resistance defined in yeast cells.Retrovirology2006https://conductscience.org/library/papers/16956392PubMed
12584357Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation.J Virol2003https://conductscience.org/library/papers/12584357PubMed
11502538Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11502538PubMed
10493930Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.Biochem J1999https://conductscience.org/library/papers/10493930PubMed
9573057Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii.Infect Immun1998https://conductscience.org/library/papers/9573057PubMed
9539792NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9539792PubMed
9199451Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation.Infect Immun1997https://conductscience.org/library/papers/9199451PubMed

See all 66 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2017258

GET https://conductscience.org/api/papers/v1/2017258/cited_by?page=2